This site is intended for healthcare professionals only
LoginRegister
Akums Drugs Secures EU-GMP Certification for Two Haridwar PlantsSubmit rationality and desirability of Rizatriptan plus Naproxen: CDSCO Panel Tells Akum Drugs and...
Mankind Pharma Reports 11.5% Revenue Growth in Q3 FY26Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORA
Novartis declares positive results from phase III study for new malaria treatmentNovartis Healthcare Gets CDSCO Panel Nod To study Anti-cancer Drug Asciminib
MediBuddy ropes in Sidhartha Mehra as CFOMediBuddy ropes in Sidhartha Mehra as CFO
cyberattackCybersecurity incident at Alkem Labs US arm, investigation underway
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban
Former Coca-Cola executive Punita Lal joins Lupin Board as Additional DirectorFormer Coca-Cola executive Punita Lal joins Lupin Board as Additional Director
Lupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million MarketLupin Rivaroxaban Tablets approved by USFDA
Alembic Pharma appoints Jigr Shah as Head - Business FinanceAlembic Pharma appoints Jigr Shah as Head - Business Finance
Fixed Dose Combination of Metformin-Voglibose Now CDSCO ApprovedDTAB Agrees to Prohibit 16 FDCs Identified as Irrational
Akums Drugs Secures EU-GMP Certification for Two Haridwar PlantsCDSCO Panel Demands Structured Phase IV Protocol for Ademetionine in Liver Disease Subtypes
Mankind Pharma Reports 11.5% Revenue Growth in Q3 FY26Mankind Pharma hit with over Rs 341 crore additional tax demand from IT authority
X